Key points are not available for this paper at this time.
Here we provide qualitative measures of the magnitude and epitope specificity of the nAb responses to TDV. This information will be useful for understanding the performance of TDV in clinical trials and for identifying correlates of protective immunity.
Swanstrom et al. (2018) studied this question.